Table 1

Deaths prevented or postponed by medical and surgical treatments in Ireland in 2000

Treatments	Number of eligible patients*	% Eligible patients treated†	Absolute risk reduction	Best estimate (number)	Best estimate (%)
Based on Hospital-In-Patient Enquiry, Central Statistics Office, and General Medical Payments Databases for the year 2000 only.²³ †Treatment uptakes are weighted to sex and age groups by the year of death, and therefore not consistent with values in appendix III, and appendix III identifies the sources of treatment uptakes in Ireland for the year 2000 only. ‡This value does not include the additional 47 AMI deaths attributable to treatment effect of 1985. §This value equates to ¶ and * together and does not include two additional deaths attributable to treatment effect of 1985. ††3763 is total observed fewer CHD deaths in 2000, and 1639 sums up all the individual bold font values. ‡‡These treatments were not generally available in 1985.
Acute myocardial infarction (AMI)	3970			166‡	4.4‡
Community resuscitation		49	0.110	12	0.3
Hospital resuscitation		99	0.213	32	0.9
Thrombolysis		39‡‡	0.038	60	1.6
Aspirin		61‡‡	0.031	79	2.1
Primary angioplasty		4‡‡	0.056	8	0.2
β blockers		33	0.008	11	0.3
ACE inhibitors		19‡‡	0.001	11	0.3
Total secondary prevention				678§	18.0§
Secondary prevention after infarction	37245			449¶	11.9¶
Aspirin		64‡‡	0.010	127	3.4
β blockers		33	0.012	92	2.4
ACE inhibitors		21‡‡	0.012	53	1.4
Statins		37‡‡	0.015	83	2.2
Warfarin		4	0.008	9	0.2
Rehabilitation		51	0.014	87	2.3
Secondary prevention after revascularisation	24438		0.028	229**	6.1**
Chronic angina				317	8.4
CABG surgery	18990	100	0.009	144	3.8
Angioplasty	11023	100‡‡	0.005	45	1.2
Community angina (aspirin+statin)	78873	75‡‡	0.002	128	3.4
Unstable angina	2432			33	0.9
Aspirin and heparin		59‡‡	0.012	17	0.5
Aspirin alone		30‡‡	0.013	8	0.2
Platelet IIB/IIIA inhibitors		48‡‡	0.007	8
Heart failure			–	340	9.1
Hospital	1715	28‡‡	–	150
Community	12940	56‡‡		190	5.1
Hypertension treatment	705648	37	0.001	59	1.6
Statins for primary prevention	915169	6‡‡	0.001	46	1.2
Total treatment effects in 2000				1639/3763††	43.6